PRTT OTC
Protect Pharmaceutical Corporation
1W: +2.4%
1M: -5.6%
3M: +126.7%
YTD: +84.8%
1Y: -28.6%
3Y: -70.7%
5Y: -70.2%
$0.17
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$13M
+214.5% ▲
5Y CAGR: +302.9%
Capital Expenditures
$3M
+37.5% ▲
Free Cash Flow
$10M
+0.0% ▲
5Y CAGR: +285.4%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$552K
-103.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $6M | $20M | $22M | $46M | $56M |
| Depreciation & Amort. | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $961K | -$10M | -$92M | -$42M | -$44M |
| Other Non-Cash Items | $0 | $0 | $2M | $0 | $0 |
| Operating Cash Flow | $7M | $11M | -$67M | $4M | $13M |
| — Investing Activities — | |||||
| Capital Expenditures | -$20M | -$75M | -$2M | -$4M | -$3M |
| Acquisitions (Net) | $0 | $0 | $24M | $8M | $6M |
| Investment Purchases | $0 | -$12M | $0 | $0 | -$7M |
| Investment Sales | $0 | $0 | $0 | $5M | $0 |
| Other Investing | $0 | $105M | $24M | $4M | $0 |
| Investing Cash Flow | -$20M | $18M | $46M | $13M | -$4M |
| — Financing Activities — | |||||
| Net Debt Issuance | $13M | -$5M | -$10M | $1M | $38K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $13M | -$5M | -$10M | $2M | $38K |
| Net Change in Cash | $74K | $40M | -$39M | $17M | -$552K |
| Cash End of Period | $74K | $40M | $1M | $18M | $18M |
| Free Cash Flow | -$13M | -$65M | -$69M | $0 | $10M |